19 min listen
Regulation, regulation, regulation
FromThe BMJ Podcast
ratings:
Length:
16 minutes
Released:
Aug 28, 2013
Format:
Podcast episode
Description
A BMJ investigation this week raises concerns about the ability of the US Food and Drug Administration to monitor the safety of medical devices through post-approval surveillance. We ask: is the FDA giving device manufacturers an easy regulatory ride?
Also, the National Institute for Health and Clinical Excellence (NICE) is set to lose the power to restrict the use of any drug that exceeds its £30k cost per quality adjusted life year ceiling. Alan Maynard, professor of health economics at the University of York, discusses what this will mean.
Also, the National Institute for Health and Clinical Excellence (NICE) is set to lose the power to restrict the use of any drug that exceeds its £30k cost per quality adjusted life year ceiling. Alan Maynard, professor of health economics at the University of York, discusses what this will mean.
Released:
Aug 28, 2013
Format:
Podcast episode
Titles in the series (100)
Bias in clinical guidelines, and giving birth at home: Despite repeated calls to prohibit or limit conflicts of interests among authors and sponsors of clinical guidelines, the problem persists. Jeanne Lenzer explains what's going wrong.And is giving birth at home as safe for the mother as giving birth i... by The BMJ Podcast